Real-World Safety Profile of therapy with Ibrutinib or Acalabrutinib in patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

This content is only available as a PDF.

Author notes

Data sharing statements:

The data that support the findings of this study are available from the TriNetX Analytics Network. https://trinetx.com.

© 2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

2024